VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,537,039 | -8.0% | 159,431 | -13.1% | 0.00% | 0.0% |
| Q2 2023 | $6,020,178 | -23.1% | 183,542 | -21.4% | 0.00% | 0.0% |
| Q1 2023 | $7,829,000 | +1407993.5% | 233,650 | +1278.2% | 0.00% | – |
| Q4 2022 | $556 | -99.9% | 16,953 | +38.4% | 0.00% | – |
| Q3 2022 | $428,000 | +191.2% | 12,248 | +2.2% | 0.00% | – |
| Q2 2022 | $147,000 | +42.7% | 11,984 | +57.8% | 0.00% | – |
| Q1 2022 | $103,000 | -91.8% | 7,593 | -88.0% | 0.00% | – |
| Q4 2021 | $1,257,000 | – | 63,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |